| Recruitment status | Recruiting |
| Unique ID issued by UMIN | UMIN000022928 |
| Receipt No. | R000026414 |
| Official scientific title of the study | Multicenter, randomized controlled trials on the usefulness of the Linked Color Imaging (LCI) in synchronous and metachronous gastric cancer detection. |
| Date of disclosure of the study information | 2016/06/29 |
| Last modified on | 2016/06/28 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Multicenter, randomized controlled trials on the usefulness of the Linked Color Imaging (LCI) in synchronous and metachronous gastric cancer detection. | |
| Title of the study (Brief title) | Multicenter, randomized controlled trials on the usefulness of the Linked Color Imaging (LCI) in synchronous and metachronous gastric cancer detection. | |
| Region |
|
|
| Condition | ||
| Condition | Surveillance of gastric cancer using endoscopy. | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Aim of this study is to evaluate the usefulness of LCI for gastric cancer detection. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Detection rate of Gastric cancer by using LCI or white-light imaging (WLI). |
| Key secondary outcomes | Added efficacy of examination with LCI on the detection rate of gastric cancer in conventional WLI observation. |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is considered as a block. |
| Blocking | YES |
| Concealment | Pseudo-randomization |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Endoscopic examination with LCI before conventional WLI observation. | |
| Interventions/Control_2 | Endoscopic examination with LCI after conventional WLI observation. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Patients before undergoing an endoscopic or surgical resection of early gastric cancer or Patients with follow-up after endoscopic resection of gastric cancer.
2. Patients can perform endoscopic biopsy when necessary. 3. Patients with informed consent. |
|||
| Key exclusion criteria | 1. Patients with advanced Gastric cancer.
2. The history of surgical gastric resection. 3. Patients has determined that inappropriate by principal investigator. |
|||
| Target sample size | 1000 | |||
| Research contact person | |
| Name of lead principal investigator | Tatsuya Yamaguchi |
| Organization | Faculty of Medicine, University of Yamanashi |
| Division name | First Department of Internal Medicine |
| Address | 1110, Shimokato, Chuo, Yamanashi |
| TEL | 055-273-1111 |
| ytatsuya@yamanashi.ac.jp | |
| Public contact | |
| Name of contact person | Tatsuya Yamaguchi |
| Organization | Faculty of Medicine, University of Yamanashi |
| Division name | First Department of Internal Medicine |
| Address | 1110, Shimokato, Chuo, Yamanashi |
| TEL | 055-273-9584 |
| Homepage URL | |
| ytatsuya@yamanashi.ac.jp | |
| Sponsor | |
| Institute | University of Yamanashi |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | University of Yamanashi |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026414 |